[Effects of induced hyperglycemia on the activity of pancreatic and gastrointestinal secretion of hormones in oncologic patients].
Artificial hyperglycemia (AHG) used in the cancer treatment considerably increases the insulin and S-peptide content in blood, decreases the glucagon concentration and tissue glucose tolerance. The changes are reversible, have a functional character, that indicates the absence of a disbalance in hormonal mechanisms of carbohydrate metabolism control as well as marked disorders of the pancreas function. In order to achieve a wider range of indications for using AHG in complex schemes of the cancer treatment, it is necessary to take measures on optimization of the carbohydrate metabolism state which should be controlled by the suggested complex of laboratory tests.
V I
VI
Prokhorova
V Z
VZ
Rubanova
E A
EA
Zhavrid
S E
SE
Nodel'son
T V
TV
Khodina
S P
SP
Lappo
Iu P
IuP
Istomin
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001786:Blood Glucose; D002096:C-Peptide / Q000378:metabolism*; D050260:Carbohydrate Metabolism; D003131:Combined Modality Therapy; D005934:Glucagon / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008175:Lung Neoplasms / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D013274:Stomach Neoplasms / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*
D000970:Antineoplastic Agents; D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D005934:Glucagon
Vliianie iskusstvennoĭ giperglikemii na aktivnost' pankreaticheskoĭ i gastrointestinal'noĭ sekretsii gormonov u onkologicheskikh bol'nykh.